Creative Planning’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,305
Closed -$350K 3787
2024
Q4
$350K Buy
28,305
+8,127
+40% +$93.1K ﹤0.01% 2538
2024
Q3
$230K Buy
20,178
+6,672
+49% +$67K ﹤0.01% 2736
2024
Q2
$96.4K Buy
+13,506
New +$103K ﹤0.01% 2843
2017
Q3
Sell
-2,600
Closed -$11K 3821
2017
Q2
$11K Buy
2,600
+100
+4% +$409 ﹤0.01% 3591
2017
Q1
$11K Buy
2,500
+786
+46% +$2.63K ﹤0.01% 3553
2016
Q4
$4K Buy
1,714
+1,428
+499% +$3.34K ﹤0.01% 4076
2016
Q3
$1K Sell
286
-1,143
-80% -$3.07K ﹤0.01% 4462
2016
Q2
$4K Sell
1,429
-314
-18% -$875 ﹤0.01% 3789
2016
Q1
$5K Sell
1,743
-1,857
-52% -$9.94K ﹤0.01% 3617
2015
Q4
$29K Buy
3,600
+3,286
+1,046% +$26.5K ﹤0.01% 2579
2015
Q3
$2K Buy
+314
New +$2.62K ﹤0.01% 3992
2015
Q2
Sell
-214
Closed -$2K 3124
2015
Q1
$2K Hold
214
﹤0.01% 3917
2014
Q4
$2K Sell
214
-429
-67% -$4.32K ﹤0.01% 3863
2014
Q3
$6K Hold
643
﹤0.01% 3225
2014
Q2
$8K Hold
643
﹤0.01% 3006
2014
Q1
$9K Buy
643
+24
+4% +$316 ﹤0.01% 2819
2013
Q4
$6K Hold
619
﹤0.01% 2788
2013
Q3
$6K Hold
619
﹤0.01% 2680
2013
Q2
$6K Buy
+619
New +$6.49K ﹤0.01% 2494

Other funds holding CDMO

Creative Planning's CDMO Position: Q1 2025 in Review

Creative Planning sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 28,305 shares — an estimated $350K sold.

Creative Planning first reported a position in CDMO in Q2 2013 and held it in 19 quarters. The position peaked at $350K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Creative Planning reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Creative Planning sold 28,305 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $350K.
  • Creative Planning first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
  • Creative Planning's Avid Bioservices, Inc. Common Stock position peaked at $350K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.